Optimeos Life Sciences develops nanoparticle-enabled technologies which improve scientists' abilities to understand diseases and advance patient care through more effective diagnostics and therapeutics.

Beginning with imaging research tools, Optimeos will commercialize a best in class multi-modal imaging nanoparticle. This nanoparticle will enable researchers to visualize the earliest signs of a disease and its progression, and view the effects of therapies in vitro and in vivo.